Cargando…

Impact of different factor VIII inhibitor kinetic profiles on the inhibitor titer quantification using the modified Nijmegen–Bethesda assay

BACKGROUND: Coagulation factor VIII (FVIII) inhibitor titer quantification is vital for optimizing care in people with hemophilia A. OBJECTIVES: This study analyzed the impact of the different kinetic profiles of four FVIII monoclonal antibodies on inhibitor titer quantification using the modified N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ketteler, Carolin, Hoffmann, Ingrid, Davidson, Simon, Chen, David, Tiede, Andreas, Richter, Nina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743337/ https://www.ncbi.nlm.nih.gov/pubmed/36518189 http://dx.doi.org/10.1002/rth2.12799

Ejemplares similares

Monitoring of different factor VIII replacement products using a factor VIII one‐stage clotting assay on cobas t 511/711 analysers
por: Ketteler, Carolin, et al.
Publicado: (2021)

Conservative therapy for spinal epidural hematoma in a child with hemophilia A with high-titer VIII inhibitors
por: Wang, Guige, et al.
Publicado: (2021)

Evaluation of Global Hemostatic Assays in Response to Factor VIII Inhibitors
por: Chen, Ping, et al.
Publicado: (2019)

NIJMEGEN: Analysis meeting
Publicado: (1978)

Nijmegen breakage syndrome (NBS)
por: Chrzanowska, Krystyna H, et al.
Publicado: (2012)

The Nijmegen Questionnaire and dysfunctional breathing
por: van Dixhoorn, Jan, et al.
Publicado: (2015)

Use of the Nijmegen Questionnaire in asthma
por: Thomas, Mike, et al.
Publicado: (2015)

Use of the Nijmegen Questionnaire in asthma
por: van Dixhoorn, Jan, et al.
Publicado: (2015)

The Thai version of the Nijmegen questionnaire
por: Pakdee, Sirinthip, et al.
Publicado: (2022)

CSI: Bethesda
por: Shaw, Philip
Publicado: (2006)

Leaving Bethesda
por: Kim, Tae-Il
Publicado: (2016)

NIJMEGEN: PEPR for physics and medical applications
Publicado: (1976)

Nijmegen breakage syndrome and chronic polyarthritis
por: Pasic, Srdjan, et al.
Publicado: (2013)

Acquired Factor VIII Inhibitors: Three Cases
por: Kyaw, Tay Za, et al.
Publicado: (2013)

Influence of factor VIII level and its inhibitor titer on the therapeutic response to corticosteroids alone in the management of acquired hemophilia: A retrospective single-center study
por: Vautier, Mathieu, et al.
Publicado: (2016)

Native plasma-derived FVIII/VWF complex has lower sensitivity to FVIII inhibitors than the combination of isolated FVIII and VWF proteins. Impact on Bethesda assay titration of FVIII inhibitors
por: Bravo, M I, et al.
Publicado: (2014)

THE KINETICS OF PENETRATION : VIII. TEMPORARY ACCUMULATION
por: Osterhout, W. J. V., et al.
Publicado: (1934)

The occurrence of interval cancers in the Nijmegen screening programme.
por: Peeters, P. H., et al.
Publicado: (1989)

Cohort Profile: The Nijmegen Biomedical Study (NBS)
por: Galesloot, Tessel E, et al.
Publicado: (2017)

Repression of Factor VIII Inhibitor Development with Apoptotic Factor VIII-expressing Embryonic Stem Cells
por: Sakurai, Yoshihiko, et al.
Publicado: (2013)

Different impact of factor VIII products on inhibitor development?
por: van den Berg, H. Marijke
Publicado: (2016)

Flawed methods explain the effect of mammography screening in Nijmegen
por: Jørgensen, K J
Publicado: (2011)

An adult patient with Nijmegen Breakage Syndrome and Hodgkin's Lymphoma
por: Engel, Katharina, et al.
Publicado: (2014)

Nijmegen breakage syndrome: case report and review of literature
por: Hasbaoui, Brahim El, et al.
Publicado: (2020)

Validity and Reliability of the Turkish Version of the Nijmegen Questionnaire in Asthma
por: Çakmak, Aslıhan, et al.
Publicado: (2023)

An 89-Year-Old Man with COVID-19-Associated Coagulopathy Presenting with a Prolonged Partial Thromboplastin Time, Lupus Anticoagulant, and a High Titer of Factor VIII Inhibitor
por: Ghafouri, Sanaz, et al.
Publicado: (2020)

Postpartum Acquired Hemophilia Factor VIII Inhibitors and Response to Therapy
por: Karakuş, Volkan, et al.
Publicado: (2012)

Idiopathic Acquired Hemophilia A with Undetectable Factor VIII Inhibitor
por: Abt, Nicholas B., et al.
Publicado: (2014)

Acquired Factor VIII Inhibitor Presenting as Occult GI Bleeding
por: Pacheco Cano, Carlos I., et al.
Publicado: (2018)

Concomitant factor VIII inhibitor and lupus anticoagulant in an asymptomatic patient
por: Jacobs, Jeremy W., et al.
Publicado: (2021)

Management of Acquired Factor VIII Inhibitors With NovoSeven and Obizur
por: Miatech, Jennifer L, et al.
Publicado: (2021)

Acquired factor VIII inhibitor caused by solid tumor malignancy
por: de Bear, Olivia, et al.
Publicado: (2023)

Second edition of 'The Bethesda System for reporting cervical cytology' – atlas, website, and Bethesda interobserver reproducibility project
por: Nayar, Ritu, et al.
Publicado: (2004)

Reply: Flawed methods explain the effect of mammography screening in Nijmegen
por: Verbeek, A L M, et al.
Publicado: (2011)

Juvenile idiopathic arthritis in a child with nijmegen breakage syndrome
por: Gazda, Agnieszka, et al.
Publicado: (2014)

Reliability and Validity of the Iranian Version of Nijmegen Questionnaire in Iranians with Asthma
por: Ravanbakhsh, Majid, et al.
Publicado: (2015)

T-lymphoblastic leukemia/lymphoma in macedonian patients with Nijmegen breakage syndrome
por: Kocheva, SA, et al.
Publicado: (2016)

Assay of phospholipases A(2) and their inhibitors by kinetic analysis in the scooting mode
por: Jain, Mahendra Kumar, et al.
Publicado: (1992)

Bethesda, Manual de hematologa clínica /
Publicado: (2019)

The Bethesda System for reporting cervical cytology
por: Pangarkar, Meena A.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j0no1kc9fpvqme3fhenrmt4jit